New drug monographs are available
New drug monographs are available
The University Health System Consortium has 17 drug monographs planned for this year. Several new releases are now available. They include:
- Antidiabetic Agents (TD0100)
- Aspirin 25 mg/Extended-Release Dipyridamole 200 mg (TD0900)
- Thrombolytics for Acute Myocardial Infarction (TD0200)
- Etanercept (TD0300)
- COX-2 (TD0400)
- System Pharmacologics for VZV (TD0500)
- Bisphosphonates (TD0600)
The monographs include comprehensive evaluations of drugs that are under review or were recently approved by the Food and Drug Administration, with a special focus on those that may significantly affect patient care and hospital finances.
Each monograph includes a discussion of financial implications and contains information on indications, clinical efficacy, and adverse effects, along with a consideration of alternative drug therapies and recommendations for appropriate use.
An annual subscription for the series is $500, and individual monographs are $50.
For more information, contact the consortium at (630) 954-1700.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.